Search results
Heather Bresch (née Manchin; born June 27, 1969) is an American business executive. In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan, becoming the first woman to run a Fortune 500 pharmaceutical company. Bresch retired in 2020, upon the closing of Mylan’s combination with Upjohn.
Sep 7, 2021 · Heather Bresch, the former president and CEO of the drugmaker Mylan, worked directly with the CEO of Pfizer to keep prices of the company’s EpiPen product artificially high, according to new...
Jul 29, 2019 · (Mylan) During Mylan CEO Heather Bresch's 28-year stint there, the company has utterly transformed into a generics giant—and courted controversy along the way. And now, Bresch says she's...
About Heather Bresch In May, Heather Bresch, CEO of the generic producer Mylan, projected annual sales as high as $11.5 billion, quite a jump from 2012's $6.1 billion, her first year.
Heather Bresch is chief executive officer of Mylan, one of the largest generics and specialty pharmaceutical companies in the world. She also serves on the company’s board of directors. Mylan’s mission is to provide the world’s 7 billion people access to high quality medicine.
Aug 24, 2016 · Heather Bresch's career has risen along with her father's, a fact that has not gone unnoticed by her critics. But Bresch's corporate rise is also a modern-day success story.
Mar 17, 2022 · With a final hearing set for July, the deal puts Heather Bresch, Manchin’s daughter and Mylan’s former CEO, on track to dodge legal repercussion from a yearslong saga involving allegations of...
Jul 29, 2019 · Global pharmaceutical company Mylan NV announced its CEO and Board Director Heather Bresch will retire as the company merges with Pfizer Inc. unit Upjohn by the middle of 2020 to form a new...
Feb 28, 2022 · At a congressional hearing in September 2016, the late Rep. Elijah Cummings, the ranking Democrat on the House Oversight Committee, accused then-Mylan CEO Heather Bresch of exploiting an “old...
Sep 21, 2016 · Heather Bresch, the CEO of Mylan — which makes the EpiPen — testified in front of the House Oversight and Government Reform Committee about the drug's price Wednesday. The price of the device,...
